Metrogalen (Metronidazole)

Metronidazole is reduced within anaerobic microorganisms to generate reactive nitro radicals. These radicals bind to microbial DNA, causing strand breakage and inhibiting nucleic acid synthesis, which leads to cell death of the targeted bacteria and protozoa while sparing human cells.

The specific dosage and frequency of Metrogalen are determined by the prescribing healthcare professional based on the patient’s condition, severity, and treatment area. Patients should follow the prescriber’s instructions and the product label carefully.

Safety of topical metronidazole during pregnancy or lactation has not been definitively established. It should be used only if clearly needed and prescribed by a qualified clinician, weighing potential benefits against any possible risks to the mother and infant.

To order Metrogalen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Metrogalen (metronidazole) differs from many topical acne agents such as clindamycin or benzoyl peroxide by targeting anaerobic bacteria and protozoal organisms, offering anti‑inflammatory benefits especially useful in rosacea. Its safety profile and mechanism make it a valuable alternative when conventional antibiotics are unsuitable or resistance is a concern.

Metrogalen should be stored below 25 °C in its original packaging, protected from moisture and direct light. Keeping the product in a cool, dry place helps maintain its stability and efficacy throughout its shelf life.

Metrogalen is applied topically to the affected skin area, typically once or twice daily as directed by the prescriber. The skin should be clean and dry before application, and the medication should be spread in a thin layer without rubbing vigorously.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and systemic toxicity from excessive absorption. Patients should discontinue use and seek immediate medical attention if they experience widespread rash, swelling, difficulty breathing, or unexplained neurological symptoms.

Metrogalen should not be used by individuals with known hypersensitivity to metronidazole or any component of the formulation. It is also contraindicated on extensive broken skin, in patients with severe liver disease without medical supervision, and in those who are unable to avoid alcohol consumption while using the product.